High-Fidelity MRI Assessment of Cerebral Perfusion in Healthy Neonates Less Than 1 Week of Age.

Publication date: Feb 13, 2025

Perfusion imaging of the brain has important clinical applications in detecting neurological abnormalities in neonates. However, such tools have not been available to date. Although arterial-spin-labeling (ASL) MRI is a powerful noninvasive tool to measure perfusion, its application in neonates has encountered obstacles related to low signal-to-noise ratio (SNR), large-vessel contaminations, and lack of technical development studies. To systematically develop and optimize ASL perfusion MRI in healthy neonates under 1 week of age. Prospective. Thirty-two healthy term neonates (19 female; postnatal age 1. 9 +/- 0. 7 days). 3. 0 T; T-weighted half-Fourier single-shot turbo-spin-echo (HASTE) imaging, single-delay and multi-delay 3D gradient-and-spin-echo (GRASE) large-vessel-suppression pseudo-continuous ASL (LVS-pCASL). Three studies were conducted. First, an LVS-pCASL MRI sequence was developed to suppress large-vessel spurious signals in neonatal pCASL. Second, multiple post-labeling delays (PLDs) LVS-pCASL were employed to simultaneously estimate normative cerebral blood flow (CBF) and arterial transit time (ATT) in neonates. Third, an enhanced background-suppression (BS) scheme was developed to increase the SNR of neonatal pCASL. Repeated measure analysis-of-variance, paired t-test, spatial intraclass-correlation-coefficient (ICC), and voxel-wise coefficient-of-variation (CoV). P-value

Concepts Keywords
Healthy arterial spin labeling
Mri arterial transit time
Neonatal background suppression
Thirty cerebral blood flow
Voxel multi‐delay ASL
neonate

Semantics

Type Source Name
disease MESH abnormalities
drug DRUGBANK Sulodexide
drug DRUGBANK Flunarizine
disease IDO blood
drug DRUGBANK 5-amino-1 3 4-thiadiazole-2-thiol

Original Article

(Visited 1 times, 1 visits today)